Compass Therapeutics (CMPX) Earnings Date, Estimates & Call Transcripts $3.54 +0.26 (+8.02%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Compass Therapeutics Earnings Summary Compass Therapeutics announced Q2 2025 earnings on August 11, 2025, reporting an EPS of -$0.14, which missed the consensus estimate of -$0.13 by $0.01. With a trailing EPS of -$0.45, Compass Therapeutics' earnings are expected to decrease next year, from ($0.36) to ($0.44) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 11) -$0.13 Actual EPS (Aug. 11) -$0.14 Missed By -$0.01 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)CMPX Upcoming EarningsCompass Therapeutics' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Compass Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Compass Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataCMPX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Compass Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.15-$0.07-$0.11Q2 20253-$0.17-$0.08-$0.13Q3 20253-$0.18-$0.14-$0.15Q4 20253-$0.16-$0.07-$0.12 FY 2025 12 -$0.66 -$0.36 -$0.51 Q1 20261-$0.14-$0.14-$0.14Q2 20261-$0.13-$0.13-$0.13Q3 20261-$0.05-$0.05-$0.05Q4 20261$0.00$0.00$0.00 Compass Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/11/2025Q2 2025-$0.13-$0.14 -$0.01-$0.14--5/8/2025Q1 2025-$0.12-$0.12--$0.12--2/27/2025Q4 2024-$0.10-$0.11 -$0.01-$0.11--11/12/2024--$0.11-$0.08+$0.03-$0.08--8/12/2024--$0.10-$0.10--$0.10-$0.85M5/13/2024Q1 2024-$0.11-$0.08+$0.03-$0.08--3/21/2024Q4 2023-$0.09-$0.11 -$0.02-$0.11--11/9/2023Q3 2023-$0.11-$0.08+$0.03-$0.08-- Compass Therapeutics Earnings - Frequently Asked Questions When is Compass Therapeutics' earnings date? Compass Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on CMPX's earnings history. Did Compass Therapeutics beat their earnings estimates last quarter? In the previous quarter, Compass Therapeutics (NASDAQ:CMPX) missed the analysts' consensus estimate of ($0.13) by $0.01 with a reported earnings per share (EPS) of ($0.14). Learn more on analysts' earnings estimate vs. CMPX's actual earnings. How can I listen to Compass Therapeutics' earnings conference call? The conference call for Compass Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Compass Therapeutics' conference call transcript? The conference call transcript for Compass Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Compass Therapeutics generate each year? Compass Therapeutics (NASDAQ:CMPX) has a recorded annual revenue of $850,000.00. How much profit does Compass Therapeutics generate each year? Compass Therapeutics (NASDAQ:CMPX) has a recorded net income of -$49.38 million. CMPX has generated -$0.45 earnings per share over the last four quarters. What is Compass Therapeutics' EPS forecast for next year? Compass Therapeutics' earnings are expected to decrease from ($0.36) per share to ($0.44) per share in the next year. More Earnings Resources from MarketBeat Related Companies Aurinia Pharmaceuticals Earnings Date WAVE Life Sciences Earnings Date Janux Therapeutics Earnings Date Edgewise Therapeutics Earnings Date Ardelyx Earnings Date Harrow Earnings Date ARS Pharmaceuticals Earnings Date Schrodinger Earnings Date Vera Therapeutics Earnings Date AbCellera Biologics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:CMPX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access